Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China · Delayed Price · Currency is CNY 134.00
+7.03 (5.54%)
At close: Mar 6, 2026
Beijing Hotgen Biotech Market Cap
Beijing Hotgen Biotech has a market cap or net worth of 11.9 billion as of March 6, 2026. Its market cap has increased by 104.59% in one year.
Market Cap
11.90B
Enterprise Value
10.86B
Revenue
407.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
134.00
Market Cap Chart
Since September 30, 2019, Beijing Hotgen Biotech's market cap has increased from 4.41B to 11.90B, an increase of 169.98%. That is a compound annual growth rate of 16.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 11.90B | -17.28% |
| Dec 31, 2025 | 14.39B | 159.78% |
| Dec 31, 2024 | 5.54B | 50.94% |
| Dec 29, 2023 | 3.67B | -34.53% |
| Dec 30, 2022 | 5.61B | -22.40% |
| Dec 31, 2021 | 7.22B | 197.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Staidson (Beijing) BioPharmaceuticals | 11.66B |
| Chengdu Olymvax Biopharmaceuticals | 11.62B |
| InventisBio | 11.42B |
| Hualan Biological Vaccine | 11.25B |
| Chengzhi | 10.45B |
| HitGen | 10.45B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 10.44B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 10.30B |